SGPL1

Across TCGA pan-cancer cohorts, SGPL1 mass-spec protein is linked to patient survival in 3 of 34 cancer types, making it a survival-associated SGPL1 data layer compared with 23 for mass-spec protein and 7 for mutation status.

The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where higher SGPL1 mass-spec protein is associated with worse overall survival. In most high-consensus cancer types, elevated SGPL1 expression acts as an unfavorable survival marker, although some lineages such as LSCC show a favorable association.

CCRCC, LUAD, and LSCC are the cancer types where SGPL1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CCRCC	OS	Median	III,IV	0.202	0.985	.007	36	view →
LUAD	OS	Tertile	II,III,IV	0.331	0.869	.017	11	view →
LSCC	DFS	Quartile	All	1.000	0.337	.004	6	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

SGPL1–CCRCC (OS)

Open the CCRCC breakdown →